J Korean Neurol Assoc.
1995 Dec;13(4):865-871.
Clobazam as An Add on Therapy in Patients with Complex
- Affiliations
-
- 1Department of Patholoogy, Severance-Hospital, Yonsei University, Korea.
Abstract
- Clobazam is one of the benzodiazepine compounds consisting of different structure compared to previously marketed other benzodiazepines. In rescent days, the antiepileptic effects of this drug has been recognized and used in epileptic patients. To confirm the efficacy and side effects of clobazam, we review the records of the 60 patients who was medicated clobazam more than 9 months. These patients had complex partial seizure with unsatisfactory control despite of adequate drug dosage and duration. Among these patients, the improved one were 23 (38. 3%), and tolerant one were 25 with 5.6 month mean remission duration. Only the 7 of 60 patients complained the adverse symptoms and this were not serious enough to discontinue medication. In conclusion, clobazam is relatively safe and efficacious medication enough to try for patients with unsatisfactory seizure control.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Efficacy of Add-on Therapy of Clobazam in Epileptic Children
- Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients
- A Case Report of Congenital Hyperekplexia in Twin
- Clinical Results of 3M Multifocal Intraocular Lens
- Efficacy of Deflazacort with Add-on Therapy in Childhood Intractable Atonic Seizure
